Consensus ISU Abxis Co., Ltd.

Equities

A086890

KR7086890001

End-of-day quote Korea S.E. Other stock markets 03:30:00 14/06/2024 am IST			5-day change	1st Jan Change
6,800 ^KRW	+1.04%		-3.95%	+12.40%

2023	ISU Abxis Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2022	Eucure Biopharma Announces Partnership with ISU ABXIS for the Development of Tri-specific Antibodies using YH003 Antibody Sequence	CI

Evolution of the average Target Price on ISU Abxis Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

26d1aafc5851130d664.EqJrGKgBCtvb1j8HphXZqOd62ofknlWdgzK3feyFUBs.SOMoR5pxQKmMmGBd7EaP_qUUjMSy5BvO2XDjK7ioYFFB7zFekXVoiK-EVA~026bc2f10c69455bd00db15dd36b1592

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

6,800 KRW

Average target price

8,000 KRW

Spread / Average Target

+17.65%

High Price Target

8,000 KRW

Spread / Highest target

+17.65%

Low Price Target

8,000 KRW

Spread / Lowest Target

+17.65%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar